MF

Melissa Fleury

TI Theravance Biopharma R&D Ip: 4 patents #9 of 51Top 20%
TC Theravance Respiratory Company: 1 patents #1 of 8Top 15%
📍 Brisbane, CA: #5 of 55 inventorsTop 10%
🗺 California: #4,328 of 67,890 inventorsTop 7%
Overall (2019): #32,542 of 560,194Top 6%
5
Patents 2019

Issued Patents 2019

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
10472335 Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Adam D. Hughes, Miroslav Rapta, Venkat R. Thalladi, R. Michael Baldwin, David L. Bourdet 2019-11-12
10358433 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more 2019-07-23
10315984 Neprilysin inhibitors Adam D. Hughes 2019-06-11
10189823 Neprilysin inhibitors Adam D. Hughes 2019-01-29
10172834 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2019-01-08